Luigi Mangione’s federal criminal trial will no longer begin this fall. A federal judge has moved the case to January 2027. The decision is intended to prevent scheduling conflicts with Mangione’s separate state murder trial in New York.
U.S. District Judge Margaret Garnett announced the revised timeline during a hearing in Manhattan on Monday. Under the new schedule, jury selection will begin on Jan. 5, 2027. Opening statements are scheduled for Jan. 25, 2027. The judge expects the federal trial to last between two and three weeks.
Mangione, 28, remains at the center of one of the nation’s most closely watched criminal cases. Prosecutors allege he fatally shot UnitedHealthcare CEO Brian Thompson outside a Manhattan hotel in December 2024. Authorities say Thompson was attending an investor conference when the shooting occurred.
The federal case was delayed because Mangione’s state murder trial is expected to begin on Sept. 8, 2026. Court officials determined the two proceedings could overlap. The revised schedule gives both sides additional time to prepare without competing trial calendars.
Mangione has pleaded not guilty in both the state and federal cases. He remains in custody while awaiting trial.
Separate Cases Continue on Different Timelines
Although the two prosecutions stem from the same alleged killing, they involve different legal charges. The state case centers on murder and related offenses. The federal prosecution focuses on allegations that Mangione crossed state lines to stalk Thompson before the fatal shooting.
Federal prosecutors contend Mangione carefully planned the attack before carrying it out in Midtown Manhattan. Investigators have alleged he used a 3D-printed firearm during the shooting. They also say he stayed at a hostel before the incident. Those allegations will be tested in court.
Mangione was arrested several days after the shooting in Pennsylvania following a nationwide manhunt. Since then, both state and federal prosecutors have pursued separate cases against him.
The legal proceedings have attracted widespread public attention. The case has generated intense media coverage and sparked debate over the U.S. healthcare system. Some supporters have portrayed Mangione as a symbol of frustration with the insurance industry. Public officials have broadly condemned the killing while emphasizing that criminal allegations must be resolved in court.
Monday’s hearing also experienced an unusual delay before proceedings began. Reports indicated Mangione was temporarily delayed by an elevator issue inside the federal courthouse. The scheduling problem did not affect the judge’s decision to postpone the trial.
With the revised calendar now in place, attention will shift first to the state prosecution this September. The outcome of that trial could shape public interest ahead of the federal proceedings next year. Regardless of the timeline, prosecutors still bear the burden of proving their case beyond a reasonable doubt, while Mangione continues to be presumed innocent unless convicted in court.